论文部分内容阅读
一、血小板疾病1.实验研究:近年来,血小板膜的研究已取得了很大进展。苏州医学院(简称苏医)用杂交瘤技术获得多种抗人血小板膜糖蛋白(GP)的单克隆抗体,其中SZ—21可抑制多种诱导剂引起的血小板二相聚集,抑制其释放功能及纤维蛋白原与血小板的结合,并证实SZ—21识别的抗原是GPⅢa;
First, the platelet disease 1. Experimental Research: In recent years, the study of platelet membrane has made great progress. Suzhou Medical College (referred to as Soviet Union) with hybridoma technology access to a variety of anti-human platelet membrane glycoprotein (GP) monoclonal antibody, which SZ-21 can inhibit a variety of inducer-induced platelet aggregation and inhibit its release function And fibrinogen and platelet binding, and confirmed SZ-21 recognized antigen is GP Ⅲ a;